Biotech · Private company
Debiopharm International SA
Track this companyFree. Adds Debiopharm International SA to your Dealase workspace and tells you when its record changes.
Clinical trials165 recruiting or active
Pipeline programs26From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline26
- Debio 4126Phase 3 · AcromegalyClinicalTrials.gov · fetched Nov 12, 2026
- Debio 4326Phase 3 · Central Precocious PubertyClinicalTrials.gov · fetched Nov 12, 2026
- Debio 1143Phase 2 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- Debio 1347Phase 2 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- Debio 1450 IVPhase 2 · Bacterial InfectionsClinicalTrials.gov · fetched Nov 12, 2026
- Debio 1450 OralPhase 2 · Bacterial InfectionsClinicalTrials.gov · fetched Nov 12, 2026
- Debio 1562Phase 2 · Diffuse Large B-Cell LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- Debio 1562MPhase 2 · Acute Myeloid LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- Debio 4228Phase 2 · Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- LinezolidPhase 2 · Bacterial InfectionsClinicalTrials.gov · fetched Nov 12, 2026
- NivolumabPhase 2 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- RadiotherapyPhase 2 · Glioblastoma IDH (Isocitrate Dehydrogenase) WildtypeClinicalTrials.gov · fetched Nov 12, 2026
- RituximabPhase 2 · Diffuse Large B-Cell LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- TemozolomidePhase 2 · Glioblastoma IDH (Isocitrate Dehydrogenase) WildtypeClinicalTrials.gov · fetched Nov 12, 2026
- Vancomycin IVPhase 2 · Bacterial InfectionsClinicalTrials.gov · fetched Nov 12, 2026
- ZedoresertibPhase 2 · Glioblastoma IDH (Isocitrate Dehydrogenase) WildtypeClinicalTrials.gov · fetched Nov 12, 2026
- CarboplatinPhase 1 · Small Cell Lung Cancer RecurrentClinicalTrials.gov · fetched Nov 12, 2026
- Debio 0123Phase 1 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- Debio 0123Phase 1 · Small Cell Lung Cancer RecurrentClinicalTrials.gov · fetched Nov 12, 2026
- Debio1347 (CH5183284)Phase 1 · Solid TumoursClinicalTrials.gov · fetched Nov 12, 2026
- EtoposidePhase 1 · Small Cell Lung Cancer RecurrentClinicalTrials.gov · fetched Nov 12, 2026
- LunresertibPhase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- RP-3500Phase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- RP-6306 (oral PKMYT1 inhibitor)Phase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- RP-6306 (oral PKMYT1 inhibitor)Phase 1 · Adult Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- ZedoresertibPhase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials16
- A Study to Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly Previously Treated With Somatostatin AnalogsPHASE3 · RECRUITING · started Nov 26, 2025ClinicalTrials.gov NCT06930625 · fetched Nov 12, 2026
- A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)PHASE1_PHASE2 · RECRUITING · started May 30, 2025ClinicalTrials.gov NCT06969430 · fetched Nov 12, 2026
- A Study to Assess the Efficacy, Safety, and Pharmacokinetics of Debio 4326 in Pediatric Participants With Central Precocious Puberty (LIBELULA™ Clinical Trial)PHASE3 · ACTIVE_NOT_RECRUITING · started Jul 31, 2024ClinicalTrials.gov NCT06129539 · fetched Nov 12, 2026
- A Dose Finding Study of Debio 4228 in Participants With Advanced Prostate CancerPHASE2 · COMPLETED · started May 23, 2024ClinicalTrials.gov NCT06395753 · fetched Nov 12, 2026
- A Study of Zedoresertib (Debio 0123) in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Zedoresertib (Debio 0123) in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed GlioblastomaPHASE1_PHASE2 · RECRUITING · started May 15, 2023ClinicalTrials.gov NCT05765812 · fetched Nov 12, 2026
- Debio 0123 in Combination With Carboplatin and Etoposide in Adult Participants With Small Cell Lung Cancer That Recurred or Progressed After Previous Standard Platinum-Based TherapyPHASE1 · TERMINATED · started May 2, 2023ClinicalTrials.gov NCT05815160 · fetched Nov 12, 2026
- Study of RP-6306 With FOLFIRI in Advanced Solid TumorsPHASE1 · TERMINATED · started Aug 9, 2022ClinicalTrials.gov NCT05147350 · fetched Nov 12, 2026
- Study of RP-6306 With Gemcitabine in Advanced Solid TumorsPHASE1 · TERMINATED · started Dec 16, 2021ClinicalTrials.gov NCT05147272 · fetched Nov 12, 2026
- A Study to Evaluate Safety and Preliminary Anti-tumor Activity of Debio 0123 as Monotherapy in Adult Participants With Advanced Solid TumorsPHASE1 · TERMINATED · started Nov 5, 2021ClinicalTrials.gov NCT05109975 · fetched Nov 12, 2026
- Study of Lunresertib Alone or in Combination With RP-3500 or Zedoresertib (Debio 0123) in Patients With Advanced Solid TumorsPHASE1 · RECRUITING · started Apr 30, 2021ClinicalTrials.gov NCT04855656 · fetched Nov 12, 2026
- Study to Assess Safety and Efficacy of the Second Mitochondrial-derived Activator of Caspases (SMAC) Mimetic Debio 1143PHASE1_PHASE2 · COMPLETED · started Apr 26, 2019ClinicalTrials.gov NCT04122625 · fetched Nov 12, 2026
- Basket Trial in Solid Tumors Harboring a Fusion of FGFR1, FGFR2 or FGFR3- (FUZE Clinical Trial)PHASE2 · TERMINATED · started Mar 22, 2019ClinicalTrials.gov NCT03834220 · fetched Nov 12, 2026
- A Study of Debio 1347 Plus Fulvestrant in Patients With Metastatic Breast CancerPHASE1_PHASE2 · COMPLETED · started Nov 10, 2017ClinicalTrials.gov NCT03344536 · fetched Nov 12, 2026
- Study to Evaluate the Efficacy and Tolerability of Debio 1562 in Combination With Rituximab in Participants With Relapsed and/or Refractory DLBCL and Other Forms of NHLPHASE2 · COMPLETED · started Jun 5, 2016ClinicalTrials.gov NCT02564744 · fetched Nov 12, 2026
- Study of Debio 1450 for Bacterial Skin InfectionsPHASE2 · COMPLETED · started May 1, 2015ClinicalTrials.gov NCT02426918 · fetched Nov 12, 2026
- Debio 1347-101 Phase I Trial in Advanced Solid Tumours With Fibroblast Growth Factor Receptor (FGFR) AlterationsPHASE1 · TERMINATED · started Aug 1, 2013ClinicalTrials.gov NCT01948297 · fetched Nov 12, 2026